Compare LCTX & PLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LCTX | PLAY |
|---|---|---|
| Founded | 1990 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 301.7M | 357.3M |
| IPO Year | 1996 | 2011 |
| Metric | LCTX | PLAY |
|---|---|---|
| Price | $1.12 | $10.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $6.25 | ★ $23.83 |
| AVG Volume (30 Days) | 891.7K | ★ 1.3M |
| Earning Date | 05-14-2026 | 06-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | ★ $14,556,000.00 | N/A |
| Revenue This Year | $109.40 | $5.57 |
| Revenue Next Year | N/A | $5.00 |
| P/E Ratio | ★ N/A | $65.13 |
| Revenue Growth | ★ 53.24 | N/A |
| 52 Week Low | $1.00 | $9.40 |
| 52 Week High | $2.09 | $26.29 |
| Indicator | LCTX | PLAY |
|---|---|---|
| Relative Strength Index (RSI) | 48.50 | 49.42 |
| Support Level | $1.00 | $9.50 |
| Resistance Level | $1.18 | $10.98 |
| Average True Range (ATR) | 0.05 | 0.47 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 46.43 | 49.68 |
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.
Dave & Buster's Entertainment Inc is an owner and operator of entertainment and dining venues in North America that offer experiences for both adults and families under the Dave & Buster's and Main Event brands. The company combines various forms of entertainment, including games, bowling, and watching live sports and other televised events, with a full menu of entrees and appetizers and a selection of alcoholic and non alcoholic beverages, all in one location. Its concept focuses on providing customers the opportunity to Eat, Drink, Play, and Watch, appealing to a balanced mix of adults, families, and teenagers. The company also operates internationally in the early stage as a franchisor of the Dave & Buster's brand.